Erman M 1
,
Biswas B 2
,
Danchaivijitr P 3
,
Chen L 4
,
Wong YF 5
,
Hashem T 6
Show all authors
,
Lim CS 7
,
Karabulut B 8
,
Chung HJ 9
,
Chikatapu C 10
,
Ingles S 11
,
Slimane K 12
,
Kanesvaran R 13
Affiliations
- 1 Medical Oncology, Hacettepe University, Ankara, Turkey
- 2 Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India
- 3 Medical Oncology, Siriraj Hospital, Mahidol University, Bangkok, Thailand
- 4 Medical Oncology, The First Affiliated Hospital of Sun Yat-sen, Guangzhou, Guangzhou, Guangdong Province, China
- 5 Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Malaysia
- 6 Medical Oncology, Dr. Tarek Hashem's Clinic, Cairo, Egypt
- 7 Clinical Oncology, Sultan Ismail Hospital, Johor Bahru, Malaysia
- 8 Medical Oncology, Ege University, Izmir, Turkey
- 9 Department of Urology, Taipei Veterans General Hospital and Department of Urology, College of Medicine and Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
- 10 Oncology, Novartis Healthcare Pvt. Ltd., Hyderabad, Telangana, India
- 11 Oncology, Novartis Pharma AG, Basel, Switzerland
- 12 Oncology, Novartis Pharma SAS, Rueil-Malmaison, France
- 13 Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. ravindran.kanesvaran@singhealth.com.sg
PMID: 34753434
DOI: 10.1186/s12885-021-08848-8
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.